Stocks · Health care · Pharmaceutical Preparations

Dyne Therapeutics, Inc.

DYN Clue Score43

United States Fiscal year ends December CIK 0001818794 Results filed 5 Nov 2026

Add to watchlist

What the insiders did Mostly scheduled

Bought (12 mo)

$314.84K

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$168.62M

$168.57M on a plan · $0.00 straight out of an exercise

Sold at will

$48.11K

1 of 122 sales

Net

−$168.30M

+$266.73K against sales at will